EFORT CONGRESS LISBON 2022 | EXHIBITORS & SPONSORS LIST

Nested Applications

LIS22 Past EFORT Congress Exhibitions

PAST EFORT CONGRESS EXHIBITIONS

EFORT understands that in order to assess the relevance of your company exhibiting during 23rd EFORT Congress Lisbon 2022 – it is often useful to see which companies have exhibited at previous EFORT congresses. For your convenience, therefore, please find the complete exhibitor listings for the following annual congresses via the links below:

For any enquiries relating to exhibition, satellites and sponsorship – please contact by using the official exhibitors and sponsorship contact us online form.

Note* : The global Covid-19 pandemic forced EFORT to take the difficult decision to postpone the 21st and 22nd EFORT Annual Congresses that was formerly planned to be held in Vienna, Austria in June 2020 and June-July 2021 respectively.

Exhibitors Database 2022

EXHIBITORS AND PARTNERS LISTING 2022

EFORT invites you to browse through the Exhibitors Database of the 23rd EFORT Annual Congress Lisbon 2022 which represents those exhibitors that have already committed to and confirmed their presence at the 2022 EFORT Congress to be held in Lisbon, Portugal from 22 to 24 June 2022.

EFORT Industry Database


NovaBone Products LLC

13510 NW US Hwy 441
FL 32615 Alachua
United States
Phone: 001 386-462-7660
About Us

NovaBone Products was established in 2002 with a focus on developing biomaterials that harness the body’s natural healing process while meeting the specialized needs of orthopedic and dental surgeons.

We offered the first bioactive glass product to the medical community and demonstrated that our technology platform recruits, differentiates and proliferates bone cells. Today, our company offers the largest portfolio of regenerative biologics that include bone formation products, as well as products that repair and remodel tissue.

NovaBone’s bone graft substitutes and collagen matrix devices have been used for nearly two decades in millions of clinical applications with unparalleled success validating the safety and efficacy of our technology.

Area of Business: Orthopaedic Industry
Category: Biomaterials & Medical Devices
Number of Employees worldwide: 11-50 employees
Founded in: 2002
Products
Multiple bone graft products utilizing bioactive glass technology
NovaBone commercializes calcium phospho-silicate products, 100% synthetic, also called Bioactive Glass. This technology is a departure from traditional calcium phosphate bone grafts, HA (Hydroxyapatite) or TCP (Tri-calcium phosphate). HA/TCP are only osteoconductive, only a scaffold. NovaBone is bioactive synthetic. The material accelerates osteoblastic (bone cells) activity and is proven to be equivalent to autograft in clinical studies.
Category: Bone Graft Substitute